
The current CDNA market cap is 1.07B. The company's latest EPS is USD 0.9438 and P/E is 20.17.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 72.05M | 92.27M | 82.88M | 86.58M | 84.69M |
Operating Income | -19.34M | -4.1M | -10.49M | 74.69M | -13.37M |
Net Income | -16.66M | -1.39M | -7.41M | 78.01M | -10.35M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 192.19M | 296.4M | 321.79M | 280.32M | 333.79M |
Operating Income | -22.53M | -29.73M | -77.23M | -203.36M | 40.77M |
Net Income | -18.71M | -30.66M | -76.61M | -190.28M | 52.55M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 452.41M | 466.78M | 476.99M | 491.05M | 489.64M |
Total Liabilities | 196.18M | 202.11M | 203.74M | 112.62M | 110.29M |
Total Equity | 256.23M | 264.67M | 273.25M | 378.43M | 379.35M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 368.51M | 566.62M | 542.99M | 466.83M | 491.05M |
Total Liabilities | 90.83M | 100.75M | 112.08M | 205.5M | 112.62M |
Total Equity | 277.68M | 465.88M | 430.91M | 261.33M | 378.43M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -15.31M | 3.64M | 16.16M | 38.05M | -26.58M |
Investing | 27.66M | 16.03M | 1.63M | -483k | 1.33M |
Financing | -1.28M | -6.13M | -4.7M | -5.61M | -643k |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 33.43M | -19.29M | -25.24M | -18.39M | 38.05M |
Investing | -100.39M | 47.71M | -228.5M | 40.45M | -483k |
Financing | 163.15M | 185.64M | -4.54M | -29.61M | -5.61M |
Market Cap | 1.07B |
Price to Earnings Ratio | 20.17 |
Price to Sales Ratio | 3.18 |
Price to Cash Ratio | 9.24 |
Price to Book Ratio | 2.8 |
Dividend Yield | - |
Shares Outstanding | 55.68M |
Average Volume (1 week) | 868.45k |
Average Volume (1 Month) | 1.02M |
52 Week Change | 37.83% |
52 Week High | 34.84 |
52 Week Low | 13.48 |
Spread (Intraday) | 5.87 (25.36%) |
Company Name | CareDx Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.caredx.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.